Login to Your Account

Other News To Note

Wednesday, May 29, 2013
• Flamel Technologies Inc., of Lyon, France, said it exercised its right to regain control of two drugs that use its Trigger lock delivery technology that formerly were being developed in partnership with an undisclosed partner. Trigger Lock is an abuse-resistant technology for long-acting opioid analgesics.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription